HF
ADIL

HRT Financial’s Adial Pharmaceuticals ADIL Stock Holding History

HRT Financial’s Portfolio ADIL Stock Details ADIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-448
Closed -$3K – 3105
2025
Q3 		$3K Sell
448
-316
-41% -$3.08K ﹤0.01% 2764
2025
Q2 		$5K Buy
+764
New +$11.5K ﹤0.01% 2484
2024
Q3 		– Sell
-1,169
Closed -$33K – 2335
2024
Q2 		$33K Sell
1,169
-262
-18% -$9.91K ﹤0.01% 1881
2024
Q1 		$47K Buy
+1,431
New +$53.6K ﹤0.01% 1938
2023
Q1 		– Sell
-50
Closed -$6K – 2420
2022
Q4 		$6K Buy
+50
New +$8.76K ﹤0.01% 2258

Other funds holding ADIL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
MCM
Manchester Capital Management Manchester, Vermont $694M AUM 22.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HRT Financial's ADIL Position: Q4 2025 in Review

HRT Financial sold out of Adial Pharmaceuticals (ADIL) in Q4 2025, closing a stake of 448 shares — an estimated $3K sold.

HRT Financial first reported a position in ADIL in Q4 2022 and held it in 5 quarters. The position peaked at $47K in Q1 2024. 21 funds tracked by Wall St. Rank hold ADIL as of Q4 2025.

  • HRT Financial reported no remaining Adial Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 448 Adial Pharmaceuticals shares in Q4 2025, an estimated $3K.
  • HRT Financial first reported a position in Adial Pharmaceuticals in Q4 2022 and held it in 5 quarters.
  • HRT Financial's Adial Pharmaceuticals position peaked at $47K in Q1 2024.
  • 21 funds tracked by Wall St. Rank held Adial Pharmaceuticals as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.